150 related articles for article (PubMed ID: 14519914)
1. Formulation study for lansoprazole fast-disintegrating tablet. III. Design of rapidly disintegrating tablets.
Shimizu T; Sugaya M; Nakano Y; Izutsu D; Mizukami Y; Okochi K; Tabata T; Hamaguchi N; Igari Y
Chem Pharm Bull (Tokyo); 2003 Oct; 51(10):1121-7. PubMed ID: 14519914
[TBL] [Abstract][Full Text] [Related]
2. Formulation study for lansoprazole fast-disintegrating tablet. I. Effect of compression on dissolution behavior.
Shimizu T; Nakano Y; Morimoto S; Tabata T; Hamaguchi N; Igari Y
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):942-7. PubMed ID: 12913232
[TBL] [Abstract][Full Text] [Related]
3. Lansoprazole fast disintegrating tablet: a new formulation for an established proton pump inhibitor.
Baldi F; Malfertheiner P
Digestion; 2003; 67(1-2):1-5. PubMed ID: 12743433
[TBL] [Abstract][Full Text] [Related]
4. Formulation study for lansoprazole fast-disintegrating tablet. II. Effect of triethyl citrate on the quality of the products.
Shimizu T; Kameoka N; Iki H; Tabata T; Hamaguchi N; Igari Y
Chem Pharm Bull (Tokyo); 2003 Sep; 51(9):1029-35. PubMed ID: 12951443
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of fast disintegrating lansoprazole tablet in human subjects.
Iwasaki K; Yoshikawa Y; Shibata N; Takada K; Sakurai Y; Takagi N; Irie S; Nakamura K
Drug Metab Pharmacokinet; 2004 Jun; 19(3):227-35. PubMed ID: 15499190
[TBL] [Abstract][Full Text] [Related]
6. A novel method for predicting disintegration time in the mouth of rapidly disintegrating tablet by compaction analysis using TabAll.
Shibata Y; Yamamoto Y; Fujii M; Kondoh M; Watanabe Y
Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1394-5. PubMed ID: 15516774
[TBL] [Abstract][Full Text] [Related]
7. Effect of water intake on pharmacokinetics of lansoprazole from fast disintegrating tablet in human subjects.
Iwasaki K; Ito Y; Shibata N; Takada K; Sakurai Y; Takagi N; Irie S; Nakamura K
Drug Metab Pharmacokinet; 2004 Oct; 19(5):390-5. PubMed ID: 15548851
[TBL] [Abstract][Full Text] [Related]
8. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method.
Ishikawa T; Mukai B; Shiraishi S; Utoguchi N; Fujii M; Matsumoto M; Watanabe Y
Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):134-9. PubMed ID: 11217097
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
Adeoye O; Alebiowu G
Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of rapidly disintegrating tablets prepared by a direct compression method.
Bi YX; Sunada H; Yonezawa Y; Danjo K
Drug Dev Ind Pharm; 1999 May; 25(5):571-81. PubMed ID: 10219525
[TBL] [Abstract][Full Text] [Related]
11. A novel option in proton pump inhibitor dosing: lansoprazole orally disintegrating tablet dispersed in water and administered via nasogastric tube.
Freston JW; Kukulka MJ; Lloyd E; Lee C
Aliment Pharmacol Ther; 2004 Aug; 20(4):407-11. PubMed ID: 15298634
[TBL] [Abstract][Full Text] [Related]
12. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
13. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
[TBL] [Abstract][Full Text] [Related]
14. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
Liu F; Shokrollahi H
Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
[TBL] [Abstract][Full Text] [Related]
15. A novel option for dosing of proton pump inhibitors: dispersion of lansoprazole orally disintegrating tablet in water via oral syringe.
Gremse DA; Donnelly JR; Kukulka MJ; Lloyd E; Lee C
Aliment Pharmacol Ther; 2004 Jun; 19(11):1211-5. PubMed ID: 15153174
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of different fast melting disintegrants by means of a central composite design.
Di Martino P; Martelli S; Wehrlé P
Drug Dev Ind Pharm; 2005 Jan; 31(1):109-21. PubMed ID: 15704862
[TBL] [Abstract][Full Text] [Related]
17. The preparation of rapidly disintegrating tablets in the mouth.
Sugimoto M; Matsubara K; Koida Y; Kobayashi M
Pharm Dev Technol; 2001 Nov; 6(4):487-93. PubMed ID: 11775950
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole.
Alsulays BB; Kulkarni V; Alshehri SM; Almutairy BK; Ashour EA; Morott JT; Alshetaili AS; Park JB; Tiwari RV; Repka MA
Drug Dev Ind Pharm; 2017 May; 43(5):789-796. PubMed ID: 27486807
[TBL] [Abstract][Full Text] [Related]
19. Fast dispersible ibuprofen tablets.
Schiermeier S; Schmidt PC
Eur J Pharm Sci; 2002 Apr; 15(3):295-305. PubMed ID: 11923062
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
